Central American Nation of Belize Authorizes Use of Ivermectin for COVID-19

Central American Nation of Belize Authorizes Use of Ivermectin for COVID-19

Belize, a Central American nation, has joined a small but growing list of jurisdictions where the use of Ivermectin is now authorized or officially allowed for treating SARS-CoV-2, the virus behind COVID-19.  Just recently, Acting Director of Health Services for Belize’s Ministry of Health, Dr. Melissa Diaz-Musa explained the situation to local media. What triggered this decision? Well, in the recent interview it apparently is a decision based on what authorities there deem mounting evidence from a series of studies (case series, observational and a handful of actual randomized trials), significantly high safety profile, effectivity and cost. She also pointed to a growing number of established protocols, even ones discussed in America. In what will undoubtedly be deemed a controversial move by key players in research and regulatory power centers in the U.S. and Europe, the move basically represents a sort of pragmatic survival as a Latin American developing nation seeks answers to the pandemic. But TrialSite has monitored a chorus heard from an exponentially growing number of observers supporting the embrace of this drug for research purposes targeting COVID-19 at least. Purported...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee